World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
9842
World Ranking
4101
National Ranking
284

Overview

Oliver Planz is affiliated with the University of Tübingen in Germany. Their research focuses primarily on Medicine and Immunology and Microbiology, with significant contributions in Infectious Diseases, Immunology, Epidemiology, Molecular Biology, and Animal Science and Zoology.

The main topics covered in their work include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • interferon and immune responses
  • Respiratory viral infections research
  • Immune Response and Inflammation
  • vaccines and immunoinformatics approaches

Planz has published extensively in multiple venues. Frequent publication outlets include:

  • Frontiers in Immunology
  • International Journal of Molecular Sciences
  • Antiviral Research
  • Frontiers in Pharmacology
  • Research Square

Recent papers authored or co-authored by Oliver Planz include:

  • NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients (2020) in Frontiers in Immunology
  • The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses (2022) in Cellular and Molecular Life Sciences
  • Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2020) in Journal of Proteome Research
  • The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation (2023) in International Journal of Molecular Sciences
  • Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX® and BacterX® Pro (2021) in Microorganisms

Frequent co-authors collaborating with Planz are:

  • Ralf Kircheis
  • Stephan Ludwig
  • Helen Hoffmann
  • André Schreiber
  • Julia Koch-Heier

Best Publications

  • The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host

    G. Gabriel;B. Dauber;T. Wolff;Oliver Planz

  • Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

    Stephan Pleschka;Thorsten Wolff;Christina Ehrhardt;Gerd Hobom

  • Caspase 3 activation is essential for efficient influenza virus propagation

    Walter J. Wurzer;Oliver Planz;Christina Ehrhardt;Martin Giner

  • Influenza A Virus NS1 Protein Activates the PI3K/Akt Pathway To Mediate Antiapoptotic Signaling Responses

    Christina Ehrhardt;Thorsten Wolff;Stephan Pleschka;Oliver Planz

  • NF-κB-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas/FasL Is Crucial for Efficient Influenza Virus Propagation

    Walter J. Wurzer;Christina Ehrhardt;Stephan Pleschka;Friederike Berberich-Siebelt

  • Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence.

    Christina Ehrhardt;Henju Marjuki;Thorsten Wolff;Bernd Nürnberg

  • A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers

    Oliver Planz;Stephan Ehl;Esther Furrer;Edit Horvath

  • Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells

    Stephan Ludwig;Stephan Pleschka;Oliver Planz;Thorsten Wolff

  • The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors

    Stephan Ludwig;Xiuyan Wang;Christina Ehrhardt;Hongyong Zheng

  • Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappa B-inhibiting activity

    Igor Mazur;Walter J. Wurzer;Christina Ehrhardt;Stephan Pleschka

  • Influenza-virus-induced signaling cascades: targets for antiviral therapy?

    Stephan Ludwig;Oliver Planz;Stephan Pleschka;Thorsten Wolff

  • A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance

    Christina Ehrhardt;Eike R. Hrincius;Virginia Korte;Igor Mazur

  • NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.

    Ralf Kircheis;Emanuel Haasbach;Daniel Lueftenegger;Willm T. Heyken

  • Membrane Accumulation of Influenza A Virus Hemagglutinin Triggers Nuclear Export of the Viral Genome via Protein Kinase Cα-mediated Activation of ERK Signaling

    Henju Marjuki;Mohammad I. Alam;Christina Ehrhardt;Ralf Wagner

  • MEK inhibition impairs influenza B virus propagation without emergence of resistant variants

    Stephan Ludwig;Thorsten Wolff;Christina Ehrhardt;Walter Jürgen Wurzer

  • Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.

    Ruth Pinto;Susanne Herold;Lidija Cakarova;Katrin Hoegner

  • CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice.

    Karoline Droebner;Christina Ehrhardt;Anne Poetter;Stephan Ludwig

  • Viral targeting of the interferon-β-inducing Traf family member-associated NF-κB activator (TANK)-binding kinase-1

    Gunhild Unterstab;Stephan Ludwig;Aline Anton;Oliver Planz

  • Rac1 and PAK1 are upstream of IKK-ε and TBK-1 in the viral activation of interferon regulatory factor-3

    Christina Ehrhardt;Christian Kardinal;Walter J. Wurzer;Thorsten Wolff

  • European swine virus as a possible source for the next influenza pandemic

    S. Ludwig;L. Stitz;O. Planz;H. Van

Frequent Co-Authors

Stephan Ludwig
Stephan Ludwig University of Münster
Stephan Pleschka
Stephan Pleschka University of Giessen
Thorsten Wolff
Thorsten Wolff Robert Koch Institute
Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Ulrich S. Schubert
Ulrich S. Schubert Friedrich Schiller University Jena
Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Hans Hengartner
Hans Hengartner University of Zurich
Sascha Rohn
Sascha Rohn Technical University of Berlin
Hans-Dieter Klenk
Hans-Dieter Klenk Philipp University of Marburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, several related online degrees offer flexible options to advance your education and career. Students with diverse backgrounds, including those wondering what can a felon go to college for, can explore programs that open doors to the sciences and healthcare fields.

One promising pathway is becoming a Functional Medicine Nurse Practitioner, which combines holistic patient care with scientific knowledge. Online functional medicine NP programs provide specialized training that complements microbiology expertise and supports a growing healthcare niche.

For those interested in the administrative side of healthcare, pursuing a career through professional coder certification can be a strategic move. This field benefits from a microbiology foundation, especially in handling medical records and billing codes accurately for laboratory services.

Additionally, studying health data management aligns well with microbiology graduates looking to pivot to managerial roles. Understanding healthcare information management salary prospects highlights the value of these careers, offering competitive pay and opportunities to impact healthcare systems effectively.

Best Scientists Citing Oliver Planz

Trending Scientists